{"id":1022356,"date":"2026-11-18T16:04:04","date_gmt":"2026-11-18T21:04:04","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/paul-j-clancy-and-ian-bell-to-join-align-technology-board-of-directors\/"},"modified":"2026-11-18T16:04:04","modified_gmt":"2026-11-18T21:04:04","slug":"paul-j-clancy-and-ian-bell-to-join-align-technology-board-of-directors","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/paul-j-clancy-and-ian-bell-to-join-align-technology-board-of-directors\/","title":{"rendered":"Paul J. Clancy and Ian Bell to Join Align Technology Board of Directors"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwuline { text-decoration: underline }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Paul J. Clancy and Ian Bell to Join Align Technology Board of Directors<\/b><\/p>\n<p>TEMPE, Ariz. &amp; SAN JOSE, Calif.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nAlign Technology, Inc. (\u201cAlign\u201d) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign<sup>\u00ae <\/sup>System of clear aligners, iTero\u2122 intraoral scanners, and exocad\u2122 CAD\/CAM software for digital orthodontics and restorative dentistry, today announced that its Board of Directors has appointed Paul J. Clancy, a biopharmaceutical executive and former Executive Vice President and Chief Financial Officer of Alexion Pharmaceuticals, Inc. and Biogen Inc., as a director effective immediately and Ian Bell, Senior Vice President and Chief Operating Officer of Alcon Inc., as a director effective December 10, 2026.<\/p>\n<p id=\"news-body-cta\">This press release features multimedia. View the full release here: <a href=\"https:\/\/www.businesswire.com\/news\/home\/20261118992581\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20261118992581\/en\/<\/a><\/p>\n<div id=\"bwbodyimg\" style=\"width: 225px;float:left;padding-left:0px;padding-right:20px;padding-top:0px;padding-bottom:0px\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20261118992581\/en\/2975800\/4\/Paul_J_Clancy.jpg\" alt=\"Paul J. Clancy\" \/><\/p>\n<p style=\"font-size:85%\">Paul J. Clancy<\/p>\n<\/div>\n<p>\n\u201cWe are pleased to welcome Paul Clancy to our Board and look forward to the addition of Ian Bell in December,\u201d said Kevin Conroy, Chairman of the Board of Align Technology. \u201cPaul and Ian bring significant global healthcare, financial, innovation and operational leadership experience that will complement the strengths of Align\u2019s Board. Paul\u2019s deep financial and strategic leadership in the biopharmaceutical industry, together with Ian\u2019s broad perspective across commercial, manufacturing, quality and regulatory operations and his experience leading innovation-driven businesses, will be valuable as we continue to execute our strategy and drive long-term growth.\u201d<\/p>\n<p>\nMr. Clancy brings more than 30 years of strategic, financial and operational leadership experience, primarily in the biotechnology and pharmaceutical industries. He served as Executive Vice President and Chief Financial Officer of Alexion Pharmaceuticals from July 2017 to October 2019 and remained a Senior Advisor to the company until July 2020. Previously, he served as Executive Vice President and Chief Financial Officer of Biogen from 2007 to 2017, where he led the company&#8217;s financial strategy through a decade of growth. After joining Biogen in 2001 as Vice President of U.S. Marketing, he held several other senior leadership roles, including Vice President of Portfolio Management and Senior Vice President of Finance, with responsibility for treasury, tax, investor relations and business planning. Before Biogen, Mr. Clancy spent 13 years at PepsiCo in a range of finance, strategy and general management positions. He currently serves on the board of directors of Incyte Corporation, where he chairs the Audit and Finance Committee, and as Chair of the board of Sionna Therapeutics, Inc. He previously served on the boards of Exact Sciences, Xilio Therapeutics and Agios Pharmaceuticals, Inc. He is also an Executive Fellow at Harvard Business School and served as a Visiting Senior Lecturer of Finance at Cornell University&#8217;s Graduate School of Management from 2021 through May 2026. Mr. Clancy holds a B.S. in Business Administration, with a Finance concentration, from Babson College and an M.B.A. from Columbia University.<\/p>\n<p>\nMr. Bell currently serves as Senior Vice President and Chief Operating Officer of Alcon, where he oversees the company&#8217;s commercial, manufacturing, quality, and regulatory operations. Prior to assuming this role in 2024, he served as President, Global Business &amp; Innovation, leading product development across Alcon&#8217;s surgical, vision care, and digital health businesses. Previously, he served as President, International and President of Alcon&#8217;s Europe, Middle East and Africa region. Before joining Alcon in 2016, Mr. Bell held senior leadership positions at Hospira and Allergan and began his career with GlaxoSmithKline. He holds a Bachelor of Arts with honors in Economics from the University of York in the United Kingdom.<\/p>\n<p>\nMr. Clancy and Mr. Bell will be included in the company\u2019s slate of director nominees in the proxy statement for Align\u2019s 2027 Annual Meeting of Shareholders. Following the appointments of Messrs. Clancy and Bell, the Board will be composed of 13 directors until December 31, 2026, when the previously announced retirement of Mr. C. Raymond Larkin, Jr. will reduce the number of directors to 12.<\/p>\n<p><b><span class=\"bwuline\">About Align Technology, Inc.<\/span><\/b><\/p>\n<p>\nAlign Technology designs and manufactures the Invisalign\u00ae System, the most advanced clear aligner system in the world, iTero\u2122 intraoral scanners and services, and exocad\u2122 CAD\/CAM software. These technology building blocks enable enhanced digital orthodontic and restorative workflows to improve patient outcomes and practice efficiencies for over 307 thousand doctor customers and are key to accessing Align\u2019s 600 million consumer market opportunity worldwide. Over the past 29 years, Align has helped doctors treat approximately 24.2 million patients with the Invisalign System and is driving the evolution in digital dentistry through the Align\u2122 Digital Platform, our integrated suite of unique, proprietary technologies and services delivered as a seamless, end-to-end solution for patients and consumers, orthodontists and GP dentists, and lab\/partners. Visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.aligntech.com&amp;esheet=54643619&amp;newsitemid=20261118992581&amp;lan=en-US&amp;anchor=www.aligntech.com&amp;index=1&amp;md5=0bf5c4ca9540ee3fb82a3607ed2cd2df\">www.aligntech.com<\/a> for more information.<\/p>\n<p>\nFor additional information about the Invisalign system or to find an Invisalign doctor in your area, please visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.invisalign.com&amp;esheet=54643619&amp;newsitemid=20261118992581&amp;lan=en-US&amp;anchor=www.invisalign.com&amp;index=2&amp;md5=d4f4bf60e17410c7a808cbe78f22cbe7\">www.invisalign.com<\/a>. For additional information about the iTero digital scanning system, please visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.itero.com&amp;esheet=54643619&amp;newsitemid=20261118992581&amp;lan=en-US&amp;anchor=www.itero.com&amp;index=3&amp;md5=d7be9910a8a71d480f486796dc33b9d1\">www.itero.com<\/a>. For additional information about exocad dental CAD\/CAM offerings and a list of exocad reseller partners, please visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.exocad.com&amp;esheet=54643619&amp;newsitemid=20261118992581&amp;lan=en-US&amp;anchor=www.exocad.com&amp;index=4&amp;md5=4e547a757e395fbd1da6ca464918c329\">www.exocad.com<\/a>.<\/p>\n<p>\nInvisalign, iTero, exocad, Align, Align Digital Platform and iTero Lumina are trademarks of Align Technology, Inc.<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20261118992581r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20261118992581\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20261118992581\/en\/<\/a><\/span><\/p>\n<p><span class=\"bwuline\">Align Technology<br \/>\n<\/span><br \/>Madelyn Valente<br \/>\n<br \/>(909) 833-5839<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:mvalente@aligntech.com\">mvalente@aligntech.com<\/a><\/p>\n<p><span class=\"bwuline\">Zeno Group<br \/>\n<\/span><br \/>Sarah Karlson<br \/>\n<br \/>(828) 551-4201<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:sarah.karlson@zenogroup.com\">sarah.karlson@zenogroup.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> California Arizona United States North America<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Software Biotechnology Pharmaceutical Health Electronic Design Automation Medical Devices Technology Dental<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Photo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20261118992581\/en\/2975800\/3\/Paul_J_Clancy.jpg\" alt=\"Photo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\">Paul J. Clancy<\/font><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Photo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20261118992581\/en\/2975801\/3\/Ian-Bell.jpg\" alt=\"Photo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\">Ian Bell<\/font><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20261118992581\/en\/1470772\/3\/Align_tagline_vertical_RGB_charcoal_2c.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Paul J. Clancy and Ian Bell to Join Align Technology Board of Directors TEMPE, Ariz. &amp; SAN JOSE, Calif.&#8211;(BUSINESS WIRE)&#8211; Align Technology, Inc. (\u201cAlign\u201d) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign\u00ae System of clear aligners, iTero\u2122 intraoral scanners, and exocad\u2122 CAD\/CAM software for digital orthodontics and restorative dentistry, today announced that its Board of Directors has appointed Paul J. Clancy, a biopharmaceutical executive and former Executive Vice President and Chief Financial Officer of Alexion Pharmaceuticals, Inc. and Biogen Inc., as a director effective immediately and Ian Bell, Senior Vice President and Chief Operating Officer of Alcon Inc., as a director effective December 10, 2026. This press release features multimedia. View the full &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/paul-j-clancy-and-ian-bell-to-join-align-technology-board-of-directors\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Paul J. Clancy and Ian Bell to Join Align Technology Board of Directors&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1022356","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Paul J. Clancy and Ian Bell to Join Align Technology Board of Directors - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/paul-j-clancy-and-ian-bell-to-join-align-technology-board-of-directors\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Paul J. Clancy and Ian Bell to Join Align Technology Board of Directors - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Paul J. Clancy and Ian Bell to Join Align Technology Board of Directors TEMPE, Ariz. &amp; SAN JOSE, Calif.&#8211;(BUSINESS WIRE)&#8211; Align Technology, Inc. (\u201cAlign\u201d) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign\u00ae System of clear aligners, iTero\u2122 intraoral scanners, and exocad\u2122 CAD\/CAM software for digital orthodontics and restorative dentistry, today announced that its Board of Directors has appointed Paul J. Clancy, a biopharmaceutical executive and former Executive Vice President and Chief Financial Officer of Alexion Pharmaceuticals, Inc. and Biogen Inc., as a director effective immediately and Ian Bell, Senior Vice President and Chief Operating Officer of Alcon Inc., as a director effective December 10, 2026. This press release features multimedia. View the full &hellip; Continue reading &quot;Paul J. Clancy and Ian Bell to Join Align Technology Board of Directors&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/paul-j-clancy-and-ian-bell-to-join-align-technology-board-of-directors\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-18T21:04:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20261118992581\/en\/2975800\/4\/Paul_J_Clancy.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paul-j-clancy-and-ian-bell-to-join-align-technology-board-of-directors\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paul-j-clancy-and-ian-bell-to-join-align-technology-board-of-directors\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Paul J. Clancy and Ian Bell to Join Align Technology Board of Directors\",\"datePublished\":\"2026-11-18T21:04:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paul-j-clancy-and-ian-bell-to-join-align-technology-board-of-directors\\\/\"},\"wordCount\":905,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paul-j-clancy-and-ian-bell-to-join-align-technology-board-of-directors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20261118992581\\\/en\\\/2975800\\\/4\\\/Paul_J_Clancy.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paul-j-clancy-and-ian-bell-to-join-align-technology-board-of-directors\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paul-j-clancy-and-ian-bell-to-join-align-technology-board-of-directors\\\/\",\"name\":\"Paul J. Clancy and Ian Bell to Join Align Technology Board of Directors - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paul-j-clancy-and-ian-bell-to-join-align-technology-board-of-directors\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paul-j-clancy-and-ian-bell-to-join-align-technology-board-of-directors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20261118992581\\\/en\\\/2975800\\\/4\\\/Paul_J_Clancy.jpg\",\"datePublished\":\"2026-11-18T21:04:04+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paul-j-clancy-and-ian-bell-to-join-align-technology-board-of-directors\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paul-j-clancy-and-ian-bell-to-join-align-technology-board-of-directors\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paul-j-clancy-and-ian-bell-to-join-align-technology-board-of-directors\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20261118992581\\\/en\\\/2975800\\\/4\\\/Paul_J_Clancy.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20261118992581\\\/en\\\/2975800\\\/4\\\/Paul_J_Clancy.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paul-j-clancy-and-ian-bell-to-join-align-technology-board-of-directors\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Paul J. Clancy and Ian Bell to Join Align Technology Board of Directors\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Paul J. Clancy and Ian Bell to Join Align Technology Board of Directors - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/paul-j-clancy-and-ian-bell-to-join-align-technology-board-of-directors\/","og_locale":"en_US","og_type":"article","og_title":"Paul J. Clancy and Ian Bell to Join Align Technology Board of Directors - Market Newsdesk","og_description":"Paul J. Clancy and Ian Bell to Join Align Technology Board of Directors TEMPE, Ariz. &amp; SAN JOSE, Calif.&#8211;(BUSINESS WIRE)&#8211; Align Technology, Inc. (\u201cAlign\u201d) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign\u00ae System of clear aligners, iTero\u2122 intraoral scanners, and exocad\u2122 CAD\/CAM software for digital orthodontics and restorative dentistry, today announced that its Board of Directors has appointed Paul J. Clancy, a biopharmaceutical executive and former Executive Vice President and Chief Financial Officer of Alexion Pharmaceuticals, Inc. and Biogen Inc., as a director effective immediately and Ian Bell, Senior Vice President and Chief Operating Officer of Alcon Inc., as a director effective December 10, 2026. This press release features multimedia. View the full &hellip; Continue reading \"Paul J. Clancy and Ian Bell to Join Align Technology Board of Directors\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/paul-j-clancy-and-ian-bell-to-join-align-technology-board-of-directors\/","og_site_name":"Market Newsdesk","article_published_time":"2026-11-18T21:04:04+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20261118992581\/en\/2975800\/4\/Paul_J_Clancy.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/paul-j-clancy-and-ian-bell-to-join-align-technology-board-of-directors\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/paul-j-clancy-and-ian-bell-to-join-align-technology-board-of-directors\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Paul J. Clancy and Ian Bell to Join Align Technology Board of Directors","datePublished":"2026-11-18T21:04:04+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/paul-j-clancy-and-ian-bell-to-join-align-technology-board-of-directors\/"},"wordCount":905,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/paul-j-clancy-and-ian-bell-to-join-align-technology-board-of-directors\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20261118992581\/en\/2975800\/4\/Paul_J_Clancy.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/paul-j-clancy-and-ian-bell-to-join-align-technology-board-of-directors\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/paul-j-clancy-and-ian-bell-to-join-align-technology-board-of-directors\/","name":"Paul J. Clancy and Ian Bell to Join Align Technology Board of Directors - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/paul-j-clancy-and-ian-bell-to-join-align-technology-board-of-directors\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/paul-j-clancy-and-ian-bell-to-join-align-technology-board-of-directors\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20261118992581\/en\/2975800\/4\/Paul_J_Clancy.jpg","datePublished":"2026-11-18T21:04:04+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/paul-j-clancy-and-ian-bell-to-join-align-technology-board-of-directors\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/paul-j-clancy-and-ian-bell-to-join-align-technology-board-of-directors\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/paul-j-clancy-and-ian-bell-to-join-align-technology-board-of-directors\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20261118992581\/en\/2975800\/4\/Paul_J_Clancy.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20261118992581\/en\/2975800\/4\/Paul_J_Clancy.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/paul-j-clancy-and-ian-bell-to-join-align-technology-board-of-directors\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Paul J. Clancy and Ian Bell to Join Align Technology Board of Directors"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1022356","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1022356"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1022356\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1022356"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1022356"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1022356"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}